Maruyama T, Ono H, Ishimitsu T, Takanohashi A, Yagi S
Department of Medicine, Dokkyo University School of Medicine, Tochigi, Japan.
Nihon Jinzo Gakkai Shi. 1993 Oct;35(10):1123-30.
In this study, we measured cross sectional areas of glomerular arterioles and glomerular volume in heminephrectomized spontaneously hypertensive rats (SHR) treated with a calcium antagonist, nisoldipine (NSL). We also examined the relevance of these parameters to the progression of hypertensive renal injury. Male 6-week-old SHR (n = 14) were heminephrectomized and divided into 2 groups. They were fed regular chow (control, n = 7) or chow containing 0.1% NSL (n = 7). After 12 weeks, urinary protein excretion (UpV) and systolic blood pressure (SBP) were measured. The control rats developed marked hypertension reaching 228 +/- 2 mmHg, and NSL lowered this by 27 mmHg (p < 0.001). NSL reduced UpV by 22% (p < 0.05). Microvascular cast of the kidney was prepared, and the cross sectional areas of the afferent and efferent arterioles as well as glomerular volume were measured using scanning electron microscopy. In the juxtamedullary and subcapsular glomeruli with minor abnormalities, the afferent arteriole was narrower and the glomerular volume was smaller in the NSL-treated rats than in the control rats. These results suggest that the calcium antagonist, NSL, offers the advantage of protecting kidney from hypertensive injury by reducing afferent arteriolar diameter, glomerular hypertrophy and intraglomerular pressure in heminephrectomized SHR.
在本研究中,我们测量了用钙拮抗剂尼索地平(NSL)治疗的半肾切除自发性高血压大鼠(SHR)的肾小球小动脉横截面积和肾小球体积。我们还研究了这些参数与高血压肾损伤进展的相关性。将6周龄雄性SHR(n = 14)进行半肾切除,并分为2组。一组喂常规饲料(对照组,n = 7),另一组喂含0.1% NSL的饲料(n = 7)。12周后,测量尿蛋白排泄量(UpV)和收缩压(SBP)。对照组大鼠出现明显高血压,血压达到228±2 mmHg,而NSL使血压降低了27 mmHg(p < 0.001)。NSL使UpV降低了22%(p < 0.05)。制备了肾脏微血管铸型,并用扫描电子显微镜测量了入球小动脉和出球小动脉的横截面积以及肾小球体积。在异常较轻的近髓质和被膜下肾小球中,NSL治疗组大鼠的入球小动脉比对照组窄,肾小球体积也较小。这些结果表明,钙拮抗剂NSL通过减小半肾切除SHR的入球小动脉直径、肾小球肥大和肾小球内压力,具有保护肾脏免受高血压损伤的优势。